Young and Aged Striatal Astrocyte MERFISH Panel
Ontology highlight
ABSTRACT:
ORGANISM(S): Mus musculus synthetic construct
PROVIDER: GSE262083 | GEO | 2024/10/03
REPOSITORIES: GEO
Similar Datasets
Project description:Young and Aged Striatal Astrocyte MERFISH Panel
| PRJNA1090141 | ENA
Project description:MAPK cascade in solution (no scaffold)
Description
This model describes a basic 3-
stage Mitogen Activated Protein Kinase (MAPK)
cascade in solution. This cascade is typically expressed as RAF=
=>MEK==>MAPK (alternative forms are K3==>K2==>
K1 and KKK==>KK==>K)
. The input signal is RAFK (RAF Kinase)
and the output signal is MAPKpp (
doubly phosphorylated form of MAPK)
. RAFK phosphorylates RAF once to RAFp. RAFp,
the phosphorylated form of RAF induces two phoshporylations of MEK,
to MEKp and MEKpp. MEKpp,
the doubly phosphorylated form of MEK,
induces two phosphorylations of MAPK to MAPKp and MAPKpp.
Rate constant
Reaction
a10 = 5.
MAPKPH + MAPKpp -> MAPKppMAPKPH
a1 = 1.
RAF + RAFK -> RAFRAFK
a2 = 0.5
RAFp + RAFPH -> RAFpRAFPH
a3 = 3.3
MEK + RAFp -> MEKRAFp
a4 = 10.
MEKp + MEKPH -> MEKpMEKPH
a5 = 3.3
MEKp + RAFp -> MEKpRAFp
a6 = 10.
MEKPH + MEKpp -> MEKppMEKPH
a7 = 20.
MAPK + MEKpp -> MAPKMEKpp
a8 = 5.
MAPKp + MAPKPH -> MAPKpMAPKPH
a9 = 20.
MAPKp + MEKpp -> MAPKpMEKpp
d10 = 0.4
MAPKppMAPKPH -> MAPKPH + MAPKpp
d1 = 0.4
RAFRAFK -> RAF + RAFK
d2 = 0.5
RAFpRAFPH -> RAFp + RAFPH
d3 = 0.42
MEKRAFp -> MEK + RAFp
d4 = 0.8
MEKpMEKPH -> MEKp + MEKPH
d5 = 0.4
MEKpRAFp -> MEKp + RAFp
d6 = 0.8
MEKppMEKPH -> MEKPH + MEKpp
d7 = 0.6
MAPKMEKpp -> MAPK + MEKpp
d8 = 0.4
MAPKpMAPKPH -> MAPKp + MAPKPH
d9 = 0.6
MAPKpMEKpp -> MAPKp + MEKpp
k10 = 0.1
MAPKppMAPKPH -> MAPKp + MAPKPH
k1 = 0.1
RAFRAFK -> RAFK + RAFp
k2 = 0.1
RAFpRAFPH -> RAF + RAFPH
k3 = 0.1
MEKRAFp -> MEKp + RAFp
k4 = 0.1
MEKpMEKPH -> MEK + MEKPH
k5 = 0.1
MEKpRAFp -> MEKpp + RAFp
k6 = 0.1
MEKppMEKPH -> MEKp + MEKPH
k7 = 0.1
MAPKMEKpp -> MAPKp + MEKpp
k8 = 0.1
MAPKpMAPKPH -> MAPK + MAPKPH
k9 = 0.1
MAPKpMEKpp -> MAPKpp + MEKpp
Variable
IC
ODE
MAPK
0.3
MAPK'[t] == d7*MAPKMEKpp[t] + k8*MAPKpMAPKPH[t] -
a7*MAPK[t]*MEKpp[t]
MAPKMEKpp
0
MAPKMEKpp'[t] == -(d7*MAPKMEKpp[t]) - k7*MAPKMEKpp[t]
+ a7*MAPK[t]*MEKpp[t]
MAPKp
0
MAPKp'[t] == k7*MAPKMEKpp[t] - a8*MAPKp[t]*MAPKPH[t]
+ d8*MAPKpMAPKPH[t] + d9*MAPKpMEKpp[t] + k10*
MAPKppMAPKPH[t] - a9*MAPKp[t]*MEKpp[t]
MAPKPH
0.3
MAPKPH'[t] == -(a8*MAPKp[t]*MAPKPH[t]) + d8*MAPKpMAPKPH[
t] + k8*MAPKpMAPKPH[t] - a10*MAPKPH[t]*MAPKpp[t] +
d10*MAPKppMAPKPH[t] + k10*MAPKppMAPKPH[t]
MAPKpMAPKPH
0
MAPKpMAPKPH'[t] == a8*MAPKp[t]*MAPKPH[t] - d8*
MAPKpMAPKPH[t] - k8*MAPKpMAPKPH[t]
MAPKpMEKpp
0
MAPKpMEKpp'[t] == -(d9*MAPKpMEKpp[t]) - k9*MAPKpMEKpp[t]
+ a9*MAPKp[t]*MEKpp[t]
MAPKpp
0
MAPKpp'[t] == k9*MAPKpMEKpp[t] - a10*MAPKPH[t]*MAPKpp[t]
+ d10*MAPKppMAPKPH[t]
MAPKppMAPKPH
0
MAPKppMAPKPH'[t] == a10*MAPKPH[t]*MAPKpp[t] - d10*
MAPKppMAPKPH[t] - k10*MAPKppMAPKPH[t]
MEK
0.2
MEK'[t] == k4*MEKpMEKPH[t] + d3*MEKRAFp[t] -
a3*MEK[t]*RAFp[t]
MEKp
0
MEKp'[t] == -(a4*MEKp[t]*MEKPH[t]) + d4*MEKpMEKPH[t]
+ k6*MEKppMEKPH[t] + d5*MEKpRAFp[t] + k3*MEKRAFp[
t] - a5*MEKp[t]*RAFp[t]
MEKPH
0.2
MEKPH'[t] == -(a4*MEKp[t]*MEKPH[t]) + d4*MEKpMEKPH[t]
+ k4*MEKpMEKPH[t] - a6*MEKPH[t]*MEKpp[t] + d6*
MEKppMEKPH[t] + k6*MEKppMEKPH[t]
MEKpMEKPH
0
MEKpMEKPH'[t] == a4*MEKp[t]*MEKPH[t] - d4*MEKpMEKPH[t]
- k4*MEKpMEKPH[t]
MEKpp
0
MEKpp'[t] == d7*MAPKMEKpp[t] + k7*MAPKMEKpp[t] +
d9*MAPKpMEKpp[t] + k9*MAPKpMEKpp[t] - a7*MAPK[t]*
MEKpp[t] - a9*MAPKp[t]*MEKpp[t] - a6*MEKPH[t]*MEKpp[t]
+ d6*MEKppMEKPH[t] + k5*MEKpRAFp[t]
MEKppMEKPH
0
MEKppMEKPH'[t] == a6*MEKPH[t]*MEKpp[t] - d6*MEKppMEKPH[
t] - k6*MEKppMEKPH[t]
MEKpRAFp
0
MEKpRAFp'[t] == -(d5*MEKpRAFp[t]) - k5*MEKpRAFp[t]
+ a5*MEKp[t]*RAFp[t]
MEKRAFp
0
MEKRAFp'[t] == -(d3*MEKRAFp[t]) - k3*MEKRAFp[t] +
a3*MEK[t]*RAFp[t]
RAF
0.4
RAF'[t] == -(a1*RAF[t]*RAFK[t]) + k2*RAFpRAFPH[t] +
d1*RAFRAFK[t]
RAFK
0.1
RAFK'[t] == -(a1*RAF[t]*RAFK[t]) + d1*RAFRAFK[t] +
k1*RAFRAFK[t]
RAFp
0
RAFp'[t] == d5*MEKpRAFp[t] + k5*MEKpRAFp[t] +
d3*MEKRAFp[t] + k3*MEKRAFp[t] - a3*MEK[t]*RAFp[t]
- a5*MEKp[t]*RAFp[t] - a2*RAFp[t]*RAFPH[t] + d2*
RAFpRAFPH[t] + k1*RAFRAFK[t]
RAFPH
0.3
RAFPH'[t] == -(a2*RAFp[t]*RAFPH[t]) + d2*RAFpRAFPH[t]
+ k2*RAFpRAFPH[t]
RAFpRAFPH
0
RAFpRAFPH'[t] == a2*RAFp[t]*RAFPH[t] - d2*RAFpRAFPH[t]
- k2*RAFpRAFPH[t]
RAFRAFK
0
RAFRAFK'[t] == a1*RAF[t]*RAFK[t] - d1*RAFRAFK[t] -
k1*RAFRAFK[t]
Generated by Cellerator Version 1.4.3 (6-March-2004) using Mathematica 5.0
for Mac OS X (November 19, 2003), March 6, 2004 12:18:07, using (PowerMac,
PowerPC,Mac OS X,MacOSX,Darwin)
author=B.E.Shapiro
This model originates from BioModels Database: A Database of Annotated Published Models (http://www.ebi.ac.uk/biomodels/). It is copyright (c) 2005-2010 The BioModels.net Team.
For more information see the terms of use
.
To cite BioModels Database, please use: Li C, Donizelli M, Rodriguez N, Dharuri H, Endler L, Chelliah V, Li L, He E, Henry A, Stefan MI, Snoep JL, Hucka M, Le Novère N, Laibe C (2010) BioModels Database: An enhanced, curated and annotated resource for published quantitative kinetic models. BMC Syst Biol., 4:92.
2024-09-02 | BIOMD0000000011 | BioModels
Project description:Purpose: IGH sequencing has revolutionized analysis of structural and functional signatures of B cell clonality. The goals of this study are to compare IGH repertoire of splenic B cells before and after knockdown of long isoform of PRLR. Methods: After amplifying the IGH repertoire of splenic B cells using PCR primers for VHJ558 variable and Cμ constant regions. For next generation sequencing (NGS), a TrueSeq library was prepared by adapter ligation to full-length products and sequenced on the MiSeq Illumina 2x150 bp platform. Results: In this project, Unique nucleotide sequences were identified, their abundances were calculated, and their complementary determining region 3 (CDR3) length, CDR3 spectrum, VDJ usage, and diversity were analyzed using the International Immunogenetics Information System (IMGT) HighV-QUEST software. Controls are included C3,C4,C5,C7,C8 and C9. LFPRLR SMO treated mice samples are: A3,A4,A5,A6,A7 and A8
2023-03-06 | GSE207186 | GEO
Project description:A1, A2, A3, A4, A5, A6, A7, A8, B1, B2, B3, B4 Raw sequence reads
| PRJNA749649 | ENA
Project description:Integrin dimers a3/b1, a6/b1 and a6/b4 are the receptors of mammary epithelial cells for Laminin, major component of the mammary basement membrane. Antibodies against a6 and a3 integrin chains serve to isolate stem cell enriched populations from mammary epithelium, however, role of integrin dimers comprising these chains in the control of mammary stem cell activity are not known. To investigate the role of Laminin-binding integrins in the control of mammary stem cell function, a3 and a6 chains were deleted from mammary basal cells in vitro using Cre-recombinase carrying adenovirus. We found that deletion of single integrin chain (either a3, or a6) did not significantly affect stem cell potential as evaluated by transplantation and mammosphere assays, whereas basal cells depleted of both a3 and a6 integrin chains (a3a6KO) presented severely diminished stem cell activity. In this study the transcriptional profiles of a3a6KO were analysed and compared to those of control cells.
2019-04-23 | GSE117120 | GEO
Project description:Currently, it is an open question how gut senses metabolic alterations and whether this is transmitted to other tissues via EVs. Here, we observed that protein packaging in gut derived EVs (GDE) from a diet induced-prediabetic mouse mode, specifically small intestine, is increased in prediabetes. Proteins related to lipid metabolism and to oxidative stress management were more abundant in prediabetic GDE compared to healthy controls. Low-fat diet: A1 to A3 high-fat diet: A4 to A6
2022-04-04 | PXD028338 | Pride
Project description:MERFISH reveals embryonic endothelial heterogeneity
| PRJNA1038713 | ENA
Project description:Spatial Transcriptomics correlated Electron Microscopy [MERFISH]
| PRJNA836863 | ENA
Project description:WES of CD14+ monocyte from one patient (patient A) and of iPS clones derived from this patient (clones A1, A2, A3, A4, A5 derived from patient A.
2019-08-31 | E-MTAB-7917 | biostudies-arrayexpress
Project description:The hematopoietic stem cell (HSC) niche has been extensively studied in bone marrow, yet a more systematic investigation into the microenvironment regulation of hematopoiesis in fetal liver is necessary. Here we investigate the spatial organization and transcriptional profile of individual cells in both wild type and Tet2-/- fetal livers, by multiplexed error robust fluorescence in situ hybridization (MERFISH). We find that specific pairs of fetal liver cell types are preferentially positioned next to each other. Ligand-receptor singling molecule pairs such as Kitl and Kit are enriched in neighboring cell types. The majority of HSCs are directly in contact with endothelial cells (ECs) in both wild type and Tet2-/- fetal livers. Loss of Tet2 increases the number of HSCs, and upregulates Wnt and Notch signaling genes in the HSC niche. Two subtypes of ECs – arterial ECs and sinusoidal ECs – and other cell types contribute distinct signaling molecules to the HSC niche. Collectively, this study provides a comprehensive picture and bioinformatic foundation for HSC spatial regulation in fetal liver.
2021-04-16 | GSE172127 | GEO